Case Report: Left atrial myxoma with confirmed Delta variant COVID-19 infection, “to treat or withhold” [version 1; peer review: 2 approved]
Nuri Dyah Indrasari,
Ariel Pradipta,
Eric Daniel Tenda,
Sally Aman Nasution,
Eka Ginanjar,
Mira Yulianti,
Ari Fahrial Syam,
Lies Dina Liastuti,
Ceva Wicaksono Pitoyo,
Imam Subekti,
Muhammad Arza Putra,
Moses Mazmur Asaf,
Muhadi Muhadi,
Anindya Pradipta Susanto
Affiliations
Nuri Dyah Indrasari
Department of Clinical Pathology, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta Pusat, DKI Jakarta, 10430, Indonesia
Ariel Pradipta
Genomik Solidaritas Indonesia (GSI) Lab, Jakarta Selatan, DKI Jakarta, 12430, Indonesia
Eric Daniel Tenda
Division of Respirology and Critical Illness, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta Pusat, DKI Jakarta, 10430, Indonesia
Sally Aman Nasution
Division of Cardiology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta Pusat, DKI Jakarta, 10430, Indonesia
Division of Cardiology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta Pusat, DKI Jakarta, 10430, Indonesia
Mira Yulianti
Division of Respirology and Critical Illness, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta Pusat, DKI Jakarta, 10430, Indonesia
Ari Fahrial Syam
Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, COVID-19 Board Dr. Cipto Mangunkusumo National General Hospital, Jakarta Pusat, DKI Jakarta, 10430, Indonesia
Lies Dina Liastuti
Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, DKI Jakarta, 10430, Indonesia
Ceva Wicaksono Pitoyo
Division of Respirology and Critical Illness, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta Pusat, DKI Jakarta, 10430, Indonesia
Imam Subekti
Division of Endocrine Metabolic and Diabetes, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, COVID-19 Board Dr. Cipto Mangunkusumo National General Hospital, Jakarta Pusat, DKI Jakarta, 10430, Indonesia
Muhammad Arza Putra
Department of Surgery, Division of Cardiothoracic and Vascular Surgery, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta Pusat, DKI Jakarta, 10430, Indonesia
Moses Mazmur Asaf
Division of Respirology and Critical Illness, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta Pusat, DKI Jakarta, 10430, Indonesia
Muhadi Muhadi
Division of Cardiology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta Pusat, DKI Jakarta, 10430, Indonesia
Anindya Pradipta Susanto
Genomik Solidaritas Indonesia (GSI) Lab, Jakarta Selatan, DKI Jakarta, 12430, Indonesia
Primary cardiac tumors (PCTs) are extremely rare entities. More than half of PCTs are benign, with myxoma being the most common tumor. Generally, simple tumor resection is the treatment of choice for benign PCTs since it has promising results that yield low complication and recurrence rates. However, in the COVID-19 pandemic era, the mitigation protocols and/or concurrent COVID-19 infection should be taken into account in patient management for the best overall outcome. To our knowledge, this is the first case report of a patient with a left atrial myxoma and systemic embolism complication in the form of an ischemic stroke, with a concurrent confirmed COVID-19 delta variant infection.